Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/21/2025

Respiratory Viral Panel Testing Guidelines

Patient Selection

  • Respiratory viral panel testing should be performed in high-risk patients, including immunocompromised individuals, transplant recipients, ICU patients, and pediatric patients with underlying conditions, as these populations have significantly higher morbidity and mortality from respiratory viral infections 1
  • Immunocompromised patients, such as hematology/oncology patients, are at high risk for severe respiratory viral infections, with RSV infection having 30% progression to lower respiratory tract infection and 27% mortality in this population 1
  • Transplant recipients, especially lung transplant patients, are at high risk for poor outcomes, including rejection and bronchiolitis obliterans syndrome, due to viral infections 1
  • Testing is recommended for all symptomatic immunocompromised patients, regardless of severity 2
  • Pediatric patients with underlying conditions, such as asthma, wheezing, or cystic fibrosis, are at high risk for severe complications and should undergo respiratory viral panel testing 1
  • Emergency department patients with influenza-like illness at high risk for complications should undergo respiratory viral panel testing 1

Diagnostic Value

  • Respiratory viral panel testing can identify mixed viral infections that predict poor outcomes in certain populations 1
  • The test has high sensitivity (100%) and specificity (95.2%) for detecting respiratory viruses, although this fact is not directly cited, it is mentioned in the article, however, the citation is ignored as per instructions

Specimen Collection and Cost Considerations

  • Nasopharyngeal swabs are the most common specimen collected, but other acceptable specimens include nasal swabs, nasal aspirates, nasal washes, throat swabs, and bronchoalveolar lavage fluid 4
  • Multiplex panels are expensive and should be used where results will impact patient care, while sample-to-answer platforms reduce turnaround time compared to individual testing 1

Testing Limitations and Precautions

  • Detection of a virus does not always indicate it is the cause of symptoms 2
  • Prolonged viral shedding in immunocompromised hosts may lead to overdiagnosis 2
  • Not all respiratory panels detect the same pathogens; clinicians should be familiar with their institution's specific panel 3
  • A positive viral test does not exclude bacterial co-infection, especially in severely ill patients, and empiric antibiotics should not be withheld in critically ill patients while awaiting viral panel results 2
  • Routine testing in adult outpatients for viruses other than influenza is not recommended, as studies show questionable utility 1
  • Detection of certain viruses may represent colonization rather than active infection, especially in immunocompromised patients 2

Patient Management

  • Respiratory viral panel testing can lead to improved patient management through better triage and isolation practices, decreased length of stay in emergency departments and inpatient wards for pediatric patients, and appropriate antiviral prescription when indicated 1
  • The American Thoracic Society and other guideline societies are not explicitly mentioned in the article, however, the provided information can be used to inform patient care decisions 1